Engene Therapeutics Inc (ENGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
(Values in U.S. thousands)
| 04-2026 | 01-2026 | 10-2025 | 07-2025 | 04-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 29,827 | 36,613 | 50,152 | 32,623 | 57,545 |
| Marketable Securities | 228,713 | 239,409 | 143,663 | 169,362 | 159,919 |
| Receivables | 822 | 1,197 | 927 | 709 | 533 |
| TOTAL | $270,000 | $289,216 | $201,391 | $211,312 | $227,974 |
| Non-Current Assets | |||||
| PPE Net | 2,335 | 2,441 | 2,477 | 1,879 | 1,553 |
| Investments And Advances | 26,709 | 36,601 | 8,522 | 23,011 | 34,109 |
| Other Non-Current Assets | 8,480 | 8,855 | 9,078 | 9,348 | 3,015 |
| TOTAL | $37,524 | $47,897 | $20,077 | $34,238 | $38,677 |
| Total Assets | $307,524 | $337,113 | $221,468 | $245,550 | $266,651 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,793 | 2,435 | 6,688 | 2,384 | 1,567 |
| Accrued Expenses | 17,212 | 19,668 | 15,275 | 11,117 | 12,433 |
| TOTAL | $21,485 | $24,609 | $31,979 | $20,440 | $18,001 |
| Non-Current Liabilities | |||||
| Long Term Debt | 24,910 | 24,736 | 15,324 | 17,706 | 20,023 |
| Other Non-Current Liabilities | 5,961 | 6,222 | 6,455 | 6,732 | 1,336 |
| TOTAL | $30,871 | $30,958 | $21,779 | $24,438 | $21,359 |
| Total Liabilities | $52,356 | $55,567 | $53,758 | $44,878 | $39,360 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 66,989 | 66,989 | 66,985 | 51,192 | 51,105 |
| Common Shares | 631,995 | 631,992 | 513,281 | 510,164 | 510,121 |
| Retained earnings | -432,011 | -401,784 | -372,032 | -334,152 | -305,161 |
| Other shareholders' equity | -1,141 | -842 | -888 | -1,209 | -969 |
| TOTAL | $255,168 | $281,546 | $167,710 | $200,672 | $227,291 |
| Total Liabilities And Equity | $307,524 | $337,113 | $221,468 | $245,550 | $266,651 |